10th AGM concluded; all 3 resolutions passed with over 98% majority

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹22.62

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-3.7% vs market

Healthcare Services peers, median of 66sector · industry level-0.8%-4.2% vs sector

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 4.2 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-1.3-3.7-0.8-4.2

Next day

-9.7-1.3-8.4-1.9-7.8

-9.7+0.0-9.7-1.4-8.3

—-0.2—-2.4—

—-3.0—-4.3—

—-2.7—-2.7—

—-1.7—-4.9—

15d

—-8.9—-8.1—

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 66Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vanta Bioscience held its 10th AGM on September 30, 2026 in Secunderabad with 10 members present physically. All 3 resolutions were passed with the requisite majority. Resolution 1 (adoption of FY26 audited standalone and consolidated financials) got 98.70 percent in favor. Resolutions 2 and 3 (re-appointment of Managing Director Mr. Dopesh Raja Mulakala) each got 98.44 percent. Around 1.30 to 1.56 percent votes were against, mostly from public non-institutional shareholders voting via e-voting.

Likely market impact

Routine AGM business completed. Strong shareholder backing for management continuity. No material governance concerns.